IBC Life Sciences, Hyatt Regency Bethesda
February 5-6, 2009
IBC’s Inaugural Orphan Diseases conference is the premier conference to attend if you are involved or interested in research and discovery, drug development, clinical trials, regulatory affairs, funding or the commercialization of orphan disease therapies and cures. It delivers valuable information in a strategically organized and refined format for both industry and non-profit organizations looking to discuss, analyze and assess the best approaches to overcome the scientific and business challenges involved in developing an orphan disease therapeutic drug. You will learn from government and regulatory experts, industry leaders and visionaries who will offer sound practical advice.